Nachrichten zur Twist Bioscience Corp Aktie

Twist Bioscience shares drop 9% on wider than expected Q4 loss…

Key PointsEarnings per share (GAAP) came in at $0.33, beating analyst estimates by $0.87 (GAAP) and marking a dramatic turnaround…

Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do…

Twist Bioscience (TWST) delivered earnings and revenue surprises of -17.86% and 0.95%, respectively, for the quarter ended March 2025. Do…

Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest…

Twist Bioscience (TWST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

Scotiabank lifts Twist Bioscience target to $62, keeps top rating…

Twist Bioscience (TWST) delivered earnings and revenue surprises of 14.52% and 2.04%, respectively, for the quarter ended December 2024. Do…

Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs.…

Twist Bioscience exec sells $14,189 in stock…

Die Twist Bioscience Corporation verzeichnete am 7. Dezember 2024 eine bemerkenswerte Entwicklung an der Börse. Der Aktienkurs stieg um 3,86…

Ark Invest chief Cathie Wood is known for scooping up shares of innovators early in their growth stories and holding…

…

…

…

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…

Barclays maintains Overweight on Twist Bioscience shares, sees opportunity…

…

…

Earnings call: Twist Bioscience sees robust revenue growth in Q2…

Cathie Wood’s ARK ETFs buy Roku, Twist Bioscience stock…

Twist Bioscience CEO sells over $37k in company stock…

Twist Bioscience executive sells shares worth over $7,700…